AbbVie is paying ADARx Pharmaceuticals $335 million upfront to secure options on next-gen small interfering RNA (siRNA) ...

Fintel reports that on May 14, 2025, Citigroup downgraded their outlook for AbbVie (NYSE:ABBV) from Buy to Neutral. Analyst ...

Samples couriered between Auckland and Wellington have been mislaid twice, according to union representing lab workers.

Fintel reports that on May 14, 2025, Leerink Partners downgraded their outlook for iTeos Therapeutics (NasdaqGM:ITOS) from ...

Pollen is one of the most common triggers of seasonal allergies, according to the Asthma and Allergy Foundation of America. A ...

Private businesses that give away all profits and also succeed as businesses are scarce; the Newman’s Own food branding ...

Among the most serious problems contributing to K-12 science education’s decline, they noted, were a general degradation of ...

Healthcare Contract Research Outsourcing Market share globally was worth USD 73.11 billion in 2024 and is anticipated to grow ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it ...

Collaboration combines Novo Nordisk's scientific leadership in obesity and cardiometabolic diseases with Septerna's expertise in G protein-coupled receptor (GPCR) drug discovery Goal is to develop mul ...

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

If you experience seasonal allergies, you might’ve heard that eating honey can help curb or even cure the unpleasant symptoms. The idea is that the pollen in honey can help desensitize the body to the ...